Naradja Wissmar: Raised IL-32 as a Hint to Long-Term Immune Activation Post-COVID
Naradja Wissmar, Former Administrator at Karolinska Institute, shared on LinkedIn:
”University of Milan teams found SARS-CoV-2 exposure raised blood IL 32, an inflammatory cytokine, and levels stayed high at least 1 year after severe COVID 19, hinting at lingering immune activation and a biomarker for long term effects.”
Title: Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels
Authors: Lorenzo Miano, Elena Sinopoli, Alessandro Cherubini, Chiara Suffritti, Serena Pelusi, Fatima Rahmeh, Giuseppe Enzo Lamorte, Flora Peyvandi, Francesco Blasi, Giacomo Grasselli, Alessandra Bandera, Roberta Gualtierotti, Daniele Prati, Luca Vittorio Carlo Valenti
Read the Full Article on Frontiers
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 13:51Matías J Alet: Hospital Carlos Saporiti on the Path to Essential Stroke Center Recognition
-
Apr 15, 2026, 13:39Congratulations to Sandy Middleton for Taking the 2026 HESTA Australian Nursing and Midwifery Awards – Stroke Foundation
-
Apr 15, 2026, 13:25Wolfgang Miesbach: Platelet Variation and How Do They Move Over Time?
-
Apr 15, 2026, 12:44Marwa Elnahas: 4Ts Scoring Tool for Heparin – Induced Thrombocytopenia
-
Apr 15, 2026, 12:27Laurent Bertoletti: Joining Global Experts to Improve Thrombosis Care in Cancer for the ICTHIC 16th Edition
-
Apr 15, 2026, 12:13Francesco Antonio Veneziano: JCDD MDPI Calls for Papers on Advances in Thrombosis and Antithrombotic Therapy
-
Apr 15, 2026, 11:05Julius Kyei Baffour: Understanding Thrombophilia Testing and Patient Risk
-
Apr 15, 2026, 09:10Shall I Bleed Less with Age? Just 2 Weeks Until the Webinar – EHC
-
Apr 15, 2026, 08:51Moustafa Abdou: Sutimlimab is Transforming Outcomes in Cold Agglutinin Disease